Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome

Linnea M. Baudhuin, Lawrence J. Burgart, Olga Leontovich, Stephen N Thibodeau

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

It is now generally recognized that a specific subset of those patients clinically defined as having hereditary non polyposis colon cancer (HNPCC) have germline mutations in any one of several genes involved in DNA mismatch repair (MMR). This important subset of HNPCC families is now defined as having Lynch syndrome. A considerable amount of data has shown that tumors from patients with Lynch syndrome have characteristic features resulting from the underlying molecular involvement of defective MMR, that is, the presence of microsatellite instability (MSI) and the absence of MMR protein expression by immunohistochemistry (IHC). As a result, identifying patients with Lynch syndrome can now be accomplished by testing tumors for these tumor-related changes. Together, MSI and IHC are powerful tools that help identify individuals at risk for having Lynch syndrome and to distinguish these cases from HNPCC cases with other hereditary gene defects. Furthermore, IHC analysis provides valuable clues as to which MMR gene is mutated, allowing for comprehensive mutational analyses of that gene. Here, we discuss the current and historical perspectives regarding MSI and IHC analyses in tumors from sporadic colon cancer and from patients with Lynch syndrome. Given this background, we also provide a testing strategy for the identification of patients at risk for Lynch syndrome and subsequent gene testing.

Original languageEnglish (US)
Pages (from-to)255-265
Number of pages11
JournalFamilial Cancer
Volume4
Issue number3
DOIs
StatePublished - Sep 2005

Fingerprint

Hereditary Nonpolyposis Colorectal Neoplasms
Microsatellite Instability
DNA Mismatch Repair
Immunohistochemistry
Colonic Neoplasms
Genes
Neoplasms
Germ-Line Mutation
Proteins

Keywords

  • HNPCC
  • Immunohistochemistry
  • Lynch syndrome
  • Microsatellite instability
  • Mismatch repair

ASJC Scopus subject areas

  • Cancer Research
  • Genetics

Cite this

Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome. / Baudhuin, Linnea M.; Burgart, Lawrence J.; Leontovich, Olga; Thibodeau, Stephen N.

In: Familial Cancer, Vol. 4, No. 3, 09.2005, p. 255-265.

Research output: Contribution to journalArticle

@article{a144a6580fed445db196636c5273fe8e,
title = "Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome",
abstract = "It is now generally recognized that a specific subset of those patients clinically defined as having hereditary non polyposis colon cancer (HNPCC) have germline mutations in any one of several genes involved in DNA mismatch repair (MMR). This important subset of HNPCC families is now defined as having Lynch syndrome. A considerable amount of data has shown that tumors from patients with Lynch syndrome have characteristic features resulting from the underlying molecular involvement of defective MMR, that is, the presence of microsatellite instability (MSI) and the absence of MMR protein expression by immunohistochemistry (IHC). As a result, identifying patients with Lynch syndrome can now be accomplished by testing tumors for these tumor-related changes. Together, MSI and IHC are powerful tools that help identify individuals at risk for having Lynch syndrome and to distinguish these cases from HNPCC cases with other hereditary gene defects. Furthermore, IHC analysis provides valuable clues as to which MMR gene is mutated, allowing for comprehensive mutational analyses of that gene. Here, we discuss the current and historical perspectives regarding MSI and IHC analyses in tumors from sporadic colon cancer and from patients with Lynch syndrome. Given this background, we also provide a testing strategy for the identification of patients at risk for Lynch syndrome and subsequent gene testing.",
keywords = "HNPCC, Immunohistochemistry, Lynch syndrome, Microsatellite instability, Mismatch repair",
author = "Baudhuin, {Linnea M.} and Burgart, {Lawrence J.} and Olga Leontovich and Thibodeau, {Stephen N}",
year = "2005",
month = "9",
doi = "10.1007/s10689-004-1447-6",
language = "English (US)",
volume = "4",
pages = "255--265",
journal = "Familial Cancer",
issn = "1389-9600",
publisher = "Springer Netherlands",
number = "3",

}

TY - JOUR

T1 - Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome

AU - Baudhuin, Linnea M.

AU - Burgart, Lawrence J.

AU - Leontovich, Olga

AU - Thibodeau, Stephen N

PY - 2005/9

Y1 - 2005/9

N2 - It is now generally recognized that a specific subset of those patients clinically defined as having hereditary non polyposis colon cancer (HNPCC) have germline mutations in any one of several genes involved in DNA mismatch repair (MMR). This important subset of HNPCC families is now defined as having Lynch syndrome. A considerable amount of data has shown that tumors from patients with Lynch syndrome have characteristic features resulting from the underlying molecular involvement of defective MMR, that is, the presence of microsatellite instability (MSI) and the absence of MMR protein expression by immunohistochemistry (IHC). As a result, identifying patients with Lynch syndrome can now be accomplished by testing tumors for these tumor-related changes. Together, MSI and IHC are powerful tools that help identify individuals at risk for having Lynch syndrome and to distinguish these cases from HNPCC cases with other hereditary gene defects. Furthermore, IHC analysis provides valuable clues as to which MMR gene is mutated, allowing for comprehensive mutational analyses of that gene. Here, we discuss the current and historical perspectives regarding MSI and IHC analyses in tumors from sporadic colon cancer and from patients with Lynch syndrome. Given this background, we also provide a testing strategy for the identification of patients at risk for Lynch syndrome and subsequent gene testing.

AB - It is now generally recognized that a specific subset of those patients clinically defined as having hereditary non polyposis colon cancer (HNPCC) have germline mutations in any one of several genes involved in DNA mismatch repair (MMR). This important subset of HNPCC families is now defined as having Lynch syndrome. A considerable amount of data has shown that tumors from patients with Lynch syndrome have characteristic features resulting from the underlying molecular involvement of defective MMR, that is, the presence of microsatellite instability (MSI) and the absence of MMR protein expression by immunohistochemistry (IHC). As a result, identifying patients with Lynch syndrome can now be accomplished by testing tumors for these tumor-related changes. Together, MSI and IHC are powerful tools that help identify individuals at risk for having Lynch syndrome and to distinguish these cases from HNPCC cases with other hereditary gene defects. Furthermore, IHC analysis provides valuable clues as to which MMR gene is mutated, allowing for comprehensive mutational analyses of that gene. Here, we discuss the current and historical perspectives regarding MSI and IHC analyses in tumors from sporadic colon cancer and from patients with Lynch syndrome. Given this background, we also provide a testing strategy for the identification of patients at risk for Lynch syndrome and subsequent gene testing.

KW - HNPCC

KW - Immunohistochemistry

KW - Lynch syndrome

KW - Microsatellite instability

KW - Mismatch repair

UR - http://www.scopus.com/inward/record.url?scp=24144493178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24144493178&partnerID=8YFLogxK

U2 - 10.1007/s10689-004-1447-6

DO - 10.1007/s10689-004-1447-6

M3 - Article

C2 - 16136387

AN - SCOPUS:24144493178

VL - 4

SP - 255

EP - 265

JO - Familial Cancer

JF - Familial Cancer

SN - 1389-9600

IS - 3

ER -